Emotion-Specific Affective Theory of Mind Impairment in Parkinson’s Disease


The neuropathology of Parkinson’s disease (PD) involves the frontal-subcortical circuit, an area responsible for processing affective theory of mind (ToM). Patients with PD are expected to experience deficits in the affective ToM. This study aims to investigate whether the ability to infer emotion in others is affected in either young-onset Parkinson’s disease (YOPD) or middle-onset PD (MOPD) patients and to test whether the impairments in affective ToM are associated with the motor symptoms. The affective ToM, global mental abilities, and clinical symptoms were assessed in a total of 107 MOPD, 30 YOPD, and 30 normal controls (NCs). The MOPD patients exhibited deficits in affective ToM to the negative and neutral valences, when compared to the participants in the NCs and YOPD group. By conducting gender-stratified analysis, the deficits in affective ToM was only found in female participants. After adjusting for demographic variables, the multiple linear regression model revealed that affective ToM predicted motor symptoms, especially in female MOPD patients. The present study may aid in the development of medical care programs by advocating for a more comprehensive therapeutic plan that includes continuous disease progression monitoring and social skills training for female MOPD patients or their caregivers.


With advances in the understanding of the neuropathological stages of Parkinson’s disease (PD), the latest research and treatment have focused on the non-motor symptoms of the disease, such as executive function1. Emerging evidence supports that non-motor symptoms (e.g., cognitive dysfunction, loss of smell, constipation) influence not only the disease progression but also the quality of life2. The non-motor symptoms may even occur before the motor symptoms; therefore, recent discussion of the definition of PD diagnosis has shifted from the original motor symptoms to non-motor symptoms3. The latest edition of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders introduced social cognition as one of the six core components of neurocognitive function, alongside memory and executive function4. Social cognition broadly refers to the processing of social information in the brain that underlies abilities such as the detection of others’ emotions and responding appropriately to these emotions. The abilities to interact effectively in a social situation and to infer other’s emotions correctly are fundamental skills for successful communication5.

A key component in the ability to infer other’s feelings involves an intact affective theory of mind (ToM)6. ToM is fundamental in everyday life but is a relatively new area in PD research7. The RMET is a traditional and well-known assessment of the affective ToM8. The test presents the participants with a series of photographed pairs of eyes that each express a given emotion and asks the participants to pick an adjective that best fit the emotion expressed by the photograph. While the effects of PD on cognitive ToM have been consistent9, current literature has yet to reach a consensus on the manifestation of PD and its effect on the patient’s affective ToM functions. Considering that the ventromedial prefrontal regions and the orbital frontostriatal circuit are crucial for processing affective ToM10,11 and that the neuropathology of PD involves the frontal-subcortical circuit12, PD patients are expected to experience difficulty in decoding others’ emotions. Based on such pathology, we assume that affective ToM is impaired in a progressive manner during the course of PD, and the affective ToM may be closely associated with motor symptoms.

Previous studies on the subject have yielded varying results. These controversial results might have been due to the heterogeneity of the PD population and methodological differences employed by the studies. For example, the patients selected in the studies by Peron et al.13 and Enrici et al.14 were relatively young (average age: 56 and 57 years old, respectively); taking into account the disease duration (10.2 and 10.5 years), the PD patients represented in these studies were patients with young-onset PD (YOPD) rather middle-onset PD (MOPD), the more representative group for PD15. A few studies have investigated the abilities of emotion detection in YOPD patients. Yoshimura and colleagues investigated the ability to recognize facial expression in a small PD sample (n = 16), and they found the emotion state decoding ability in YOPD was preserved. This intact ability may be attributed to the pathophysiology of YOPD, in which less involvement of the mesocorticolimbic system16 is expected. Gender differences in emotion recognition have almost been neglected in the PD field17. Few studies have focused on this topic. One study found that male PD patients had poor emotional recognition ability in a small PD population (10 patients in each of the male and female groups)18. Another study found that male but not female PD patients exhibited confined impairment in recognizing anger emotions19. The profile of affected ToM in different genders is not yet clear.

Another possible explanation for the inconsistent results is the various versions of the RMET used by those studies. The number of items used may explain the conflicting results20. The RMET versions used in some studies have been abbreviated versions in which 1521, 1713,22, 2023, and 2424 stimuli were used instead of the usual 3614,25,26,27,28,29,30, and the patients were asked to choose between 2 instead of 4 adjectives21,22. Furthermore, the sample sizes in previous studies had the tendency to be small13,21,23,24,25,26,27,28,29, with only a few studies recruiting more than 30 patients per group14,22. Likewise, the small sample sizes may have failed to reflect a complete clinical picture for the majority of PD patients. Moreover, the emotions depicted in the RMET can further be divided into three valences, positive, negative, and neutral31. While previous studies had only compared the RMET total scores between PD patients and those in the control group13,14,21,23,25,27,29, the present study was also interested in the differences in the subscores between the three valences, which could provide more data on the perception of the individual emotional valences.

The primary aim of this study was to investigate whether the ability to interpret emotion from a pair of photographed eyes was affected in patients with PD (either YOPD or MOPD patients); and if so, for which specific emotional valences (positive, negative, or neutral) was affective ToM hindered and for which did it remain intact. The second purpose of this study was to test the hypothesis that the motor symptoms are related to affective ToM. Furthermore, we explored the gender differences in the above two goals.


The demographic and clinical data are summarized in Table 1. There were no significant differences between the gender, educational level, or mental state of the 3 groups. There were no significant differences in the disease duration, Hoehn and Yahr (H&Y) stage, levodopa equivalent daily dose (LED), motor function (Motor Examination, MEx), motor experiences of daily living (Motor Experiences of Daily Living, motor-EDL), or non-motor experiences of daily living (Non-motor Experiences of Daily Living, nM-EDL) of the Movement Disorder Society – Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) between the 2 patient groups. The mean age of onset of the YOPD group was reasonably lower than that of the MOPD group. In addition, the mean age of the MOPD group and normal controls (NCs) were comparable, and the YOPD group was significantly younger than the other two groups.

Table 1 Demographic Characteristics and Mental State of the Study Groups.

As shown in Fig. 1, the ANOVA revealed a significant main effect of group in the total score of RMET (F2,87 = 8.217, p = 0.001). Post hoc tests indicated that the MOPD group had the worst performance on the RMET. Out of the three emotional valences of the RMET (positive, negative, and neutral), the MOPD group performed significantly poorly on decoding negative (Kruskal-Wallis chi-squared = 13.553, df = 2, p = 0.001) and neutral valences (F2,87 = 5.660, p = 0.001) compared to the YOPD or the NC group. No significant difference was found in the positive valence (F2,87 = 0.568, p = 0.569) among the three study groups.

Figure 1

The distribution of the RMET scores in the study groups (Normal = 30, YOPD = 30, MOPD = 30). Mean values and standard error of the mean (SEM, vertical bars) of RMET total score and three valence (e.g., positive, negative, neutral) scores in the three study groups. YOPD, young-onset Parkinson’s disease; MOPD, middle-onset Parkinson’s disease. *P-value < 0.05. **P-value < 0.01.

In view of the impact of gender on the RMET performance, gender-stratified analysis of RMET was conducted. As shown in Table 2, a significant main effect of group was found in the female population; however, this was not the case for male PD patients.

Table 2 Gender-stratified analysis of the RMET.

To obtain a better understanding of the relationship between RMET and PD-related clinical variables (motor and non-motor symptoms) in the 107 MOPD patients in this study, correlation analysis and multiple linear regression were conducted. Regarding the association between the RMET total score and demographic and PD-related variables, the RMET total score was positively correlated with level of education (r = 0.274, p = 0.004) and negatively correlated with prolonged disease duration (r = −0.249, p = 0.010), H&Y stage (r = −0.214, p = 0.027), nM-EDL score (r = −0.339, p = 0.001), motor-EDL score (r = −0.299, p = 0.002), and MEx score (r = −0.321, p = 0.001). No correlation was found between RMET total score and age, onset age, or LED. Concerning the correlation between the RMET total score and the specific motor symptoms (e.g., axial symptoms and bradykinesia), the RMET total score was negatively correlated with the development of bradykinesia (r = −0.292, p = 0.003), axial symptoms (r = −0.301, p = 0.002), and speech and facial expression (SFE) (r = −0.345, p < 0.001) (Fig. 2).

Figure 2

Correlations between the RMET total score and specific motor symptoms.

We further performed 12 multiple linear regression models using as dependent variables the motor and non-motor symptoms (e.g., nM-EDL, motor –EDL, and MEx score). Each regression model was adjusted for age, education, gender, disease duration, and LED. Four significant regression equations were found. In the whole PD population, the RMET total score and negative valence score were predictors of the motor-EDL and MEx scores. Because gender has an impact on ToM, we further performed 12 multiple linear regression models in each of the male and female populations. Significant regression equations were found for MEx, but not for nM-EDL and motor-EDL, in the female PD population. However, no significant regression models were found in the male population (Table 3).

Table 3 Multiple linear regression analyses in all MOPD participants and stratified by gender.


The primary objective of this study was to investigate affective ToM in patients suffering from YOPD or MOPD. We found that the MOPD patients did not infer emotions as accurately as the YOPD patients or the normal controls did. Further analysis showed that this phenomenon was only found in the female patient population and for specific emotional valences (negative and neutral). Our result was partially in accordance with previous investigations, which recruited patients with YOPD16 and MOPD25,27,29 to explore their affective ToM ability. Our research echoes previous studies that suggested that PD patients suffered from a selective impairment in facial emotion recognition of negative emotion (i.e., fear and disgust)32. The recognition of negative facial emotion expression is encoded through specific neural substrates, such as the basal ganglia, amygdala, anterior cingulate, lateral orbitofrontal cortices, and right inferior prefrontal cortex32,33,34. We further found that patients also have difficulty in inferring another’s neutral emotional state, such as contemplative and reflective state as shown through one’s eyes. To the best of our knowledge, our study is the first to compare the affective ToM ability in YOPD versus MOPD patients directly, and the gender factor was also considered. We demonstrated an impaired affective ToM for neutral valences in female MOPD patients. Our results may resolve the previous controversial findings of the affective ToM in PD patients9 by recognizing the heterogeneity in the PD population (i.e., YOPD vs. MOPD and male vs. female). Among healthy people, females tend to be better than males at judging emotions or mental states represented by eye stimuli35,36. Nevertheless, our study found that female patients with MOPD were significantly worse than female normal controls and YOPD. This finding may imply that female patients with MOPD have a vulnerable emotional recognition ability; thus, early detection and appropriate treatment are needed for the female MOPD population. Moreover, the underlying mechanism behind the impairment in negative and neutral affective ToM in MOPD patients (especially females) warrants further exploration.

We found that the affective ToM was vulnerable in MOPD, and those patients make up the most common group in PD population15. Thus, a deeper understanding about the manifestation of PD as motor and non-motor symptoms should lead to more comprehensive and complete patient care. We further recruited more MOPD patients to determine the relationships between affective ToM and non-motor symptoms. Based on the neuropathology of PD12 and reported neuroanatomy responsible for affective ToM10,11, we assumed that the affective ToM was related to the motor symptoms. Among MOPD patients, the ability to accurately infer the emotional state of others was positively correlated with patient’s education level and disease duration. However, no correlation was found between dopaminergic treatment and impairment in affective ToM; this finding was consistent with those of previous studies that concluded that LED was not correlated with RMET performance13,21,25.

After adjusting for age, education level, disease duration, and levodopa equivalent dose, we found that affective ToM predicted the motor symptoms and motor experiences of daily living. Nevertheless, affective ToM cannot predict non-motor symptoms. This phenomenon was particularly evident in the female MOPD patient population. The current findings confirmed our hypothesis that given the neuropathology of PD12 and reported neuroanatomy responsible for affective ToM, the affective ToM and motor symptoms were closely related but not correlated with other non-motor symptoms. Our findings are in line with one recent study37, although they are not consistent with Bodden et al.25. Combining the results in this study and those from Nobis et al., we suggest that the correlation between ToM and motor symptoms may be explained by the progression of the disease and pathology. Moreover, PD patients in the early stages of disease progression may have preserved affective ToM13,21,26, with difficulties sometimes emerging after 5 years23. These findings, along with those of this study, suggest that the PD manifestation may evolve over time, which would stress the importance of continuous monitoring of disease progression in order to supplement therapeutic plans as new needs arise. Furthermore, we found that the RMET total score was negatively correlated with specific motor symptoms, such as bradykinesia, axial symptoms (i.e., gait and postural instability), and impaired speech and facial expression. Our findings partially support those29 that have suggested that impaired affective ToM can be associated with the freezing of gait in patients with PD. The correlation is not unreasonable because the processing of affective ToM and axial functions (e.g., gait) may share a common substrate in the ventromedial prefrontal network, according to current understanding. And if we integrate our results with those of De Ferrari et al.29, it can be suggested that PD patients experiencing bradykinesia or axial motor symptoms are more prone to impaired affective ToM compared to patients with tremor or rigidity motor symptoms. Further studies are needed to confirm that the pathophysiology behind the various motor symptoms in PD has different implications for the patient’s affective ToM abilities. Our study is a cross-sectional study, so we cannot determine the causal relationship between motor symptoms and affective ToM. In light of the rethinking about the PD diagnosis criteria3, the diagnosis of PD might shift to the assessment of non-motor symptoms (e.g., dementia) of PD patients. Whether the affective ToM can be used as a biomarker to detect or diagnose PD is a noteworthy issue, and the development of a useful diagnostic tool is therefore needed.

Two small-sample-size studies21,25, for example, did not find an association between affective ToM and other non-motor symptoms, such as cognitive function and depressive symptoms. Nevertheless, McKinlay et al. suggested that the patient’s cognitive status was a significant predictor of performance in ToM tasks, and the same study found that visuospatial functioning plays an important mediating role in the relationship between executive dysfunction and affective ToM deficits in PD patients30. De Ferrari et al. found that the affective ToM was positively correlated with the total number of advantageous cards in the Iowa Gambling Task, a well-established task to assess executive function. The ability to infer emotions in others appeared then to be linked to the personal judgment in decision-making and to be an important factor in determining one’s social well-being29. The current study found that the MOPD patient’s affective ToM was not related to other non-motor symptoms. Future studies might evaluate the relationship between specific cognitive functions and the various emotional valences.

We recognize the lack of a more fully exploited cognitive function in the participants as one of the study limitations. Future research should investigate cognitive function, especially the patient’s executive function, in a more comprehensive manner to resolve the controversy about the relationships between cognitive function and ToM. Clarifying these relationships may be helpful in improving or retraining ToM when some research has begun to provide insights in this direction38. Next, the emotional inference ability was evaluated in the current study solely by observing photographed pairs of eyes, even though in a real social context, the understanding of other people’s emotions may involve both verbal and non-verbal language. Future studies may employ both verbal and non-verbal information in the assessment of affective ToM to provide a more comprehensive context that mimics real-life situations. Third, the current study is a cross-sectional study, and the causal relationship between ToM and clinical characteristics need to be evaluated in a longitudinal study.

In conclusion, the results indicate that MOPD patients experienced deficits in affective ToM for negative- and neutral-specific emotion states, and such deficits are more pronounced in the female patients. In addition, impairment in affective ToM was associated with the development of motor symptoms. Our study emphasizes the heterogeneity of PD patients, and the data suggest that the emotion-decoding ability was preserved in YOPD patients, while the affective ToM was vulnerable in the female MOPD patients. Therefore, the affective ToM in female MOPD patients requires more attention in further investigations. Our findings may aid in the development of educational or medical care programs by showing the need for a more comprehensive therapeutic plan that includes continuous disease progression monitoring and social skills training for PD patients or their caregivers.



A total of 107 MOPD, 30 YOPD, and 30 healthy participants as NCs were recruited. For the primary study, 60 patients with PD (30 YOPD and 30 MOPD) and 30 NCs were included for the purpose of matching for sex, education level, mental state, disease severity, and levodopa equivalent daily dose. For the second purpose, we further recruited 77 MOPD patients to explore the relationship between affective ToM and PD-related clinical characteristics. All PD patients were diagnosed with PD according to the United Kingdom PD Society Brain Bank clinical diagnostic criteria39. Patients were divided into 2 groups according to their age at onset of PD. Those with an onset age less than or equal to 49 years were classified into the YOPD group, and an onset of PD after age 50 and before 70 was classified as MOPD15. The NCs were recruited from communities. The exclusion criteria included illiteracy, atypical parkinsonism, a history of psychiatric disorders (e.g., depressive disorders or anxiety disorder), MMSE40 score lower than 24, and other neurological or serious systemic disease.

All the participants provided written informed consent prior to enrollment, in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All study procedures were approved by the ethical research committee of Kaohsiung Medical University Hospital, and all methods were performed in accordance with the approved guidelines.


Reading the mind in the eye test

The RMET is an untimed assessment that comprises 36 black-and-white photographed pairs of eyes that each depict a particular emotion8: 8 positive, 12 negative, and 16 neutral31 valences, utilizing the same algorithms used by Harkness et al.31 The participants were asked to pick an adjective (out of 4) that best fit the emotion expressed by the photograph (e.g., which of the following adjectives best describes the eye region shown: excited, relieved, shy, or despondent).

Clinical Characteristics

Before taking the RMET, participants underwent a detailed interview to disclose demographic characteristics and clinical characteristics and received a mental state evaluation. In addition, MMSE was used to measure the global mental ability in the study participants. For the patients with PD, we recorded their disease onset age and disease duration and calculated the LED, according to the recommendations of Tomlinson et al.41. The MDS-UPDRS42 and the H&Y staging criteria were used to quantify the motor symptoms and disease severity, respectively. The three parts of the MDS-UPDRS were applied:

Part I: nM-EDL, including non-motor symptoms, such as (1) neuropsychiatric, (2) sleep, and (3) gastrointestinal and autonomic disturbances;

Part II: motor-EDL, composed of 13 patient-based items; and

Part III: Motor Examination (MEx), composed of 18 rater-based objective items.

Statistical Analysis

All variables were tested for normal distribution using the Kolmogorov-Smirnov test. The study groups were compared using the t test and one-way analysis of variance (ANOVA) with the Scheff post hoc test (P < 0.05) for parametric variables and the chi-square test, Mann–Whitney U test, and Kruskal–Wallis test for nonparametric variables. Statistical significance was determined when the probability value was less than 0.05. Moreover, multivariate linear regression analyses were performed to explain the relationships between RMET and PD patients’ clinical characteristics. For the multivariate linear regression analysis, RMET total score, positive valence, negative valence and neutral valence scores were considered as independent variables, while dependent variables were nM-EDL, motor-EDL, and MEx. We carried out four multiple linear regression models with adjustment for age, education, gender, duration, and LED in all participants. Furthermore, we stratified the subjects by gender and conducted four multiple linear regression models in males and four in females. All the variables met the assumptions of regression analysis, with the exception of the nM-EDL and MEx. The nM-EDL and MEx were not normally distributed, so the variables were log-transformed, and they had a normal distribution thereafter. Commercially available software (SPSS version 21.0; SPSS Inc., Chicago, IL, USA) was used for the statistical analyses.


  1. 1.

    Dirnberger, G. & Jahanshahi, M. Executive dysfunction in Parkinson’s disease: a review. J Neuropsychol 7, 193–224, https://doi.org/10.1111/jnp.12028 (2013).

    Article  PubMed  Google Scholar 

  2. 2.

    Pfeiffer, R. F. Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1), S119–122, https://doi.org/10.1016/j.parkreldis.2015.09.004 (2016).

    MathSciNet  Article  PubMed  Google Scholar 

  3. 3.

    Berg, D. et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson’s disease. Movement Disorders 29, 454–462 (2014).

    Article  Google Scholar 

  4. 4.

    Arbanas, G. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Alcoholism and Psychiatry Research 51, 61 (2015).

    Google Scholar 

  5. 5.

    Frith, C. D. & Frith, U. Interacting minds–a biological basis. Science 286, 1692–1695 (1999).

    CAS  Article  Google Scholar 

  6. 6.

    Shamay-Tsoory, S. G., Harari, H., Aharon-Peretz, J. & Levkovitz, Y. The role of the orbitofrontal cortex in affective theory of mind deficits in criminal offenders with psychopathic tendencies. Cortex 46, 668–677 (2010).

    Article  Google Scholar 

  7. 7.

    Mason, S. L. & Barker, R. A. Cognitive Deficits in Early Parkinson’s Disease: New Areas of Research. Current Translational Geriatrics and Experimental Gerontology Reports 1, 39–44 (2012).

    Article  Google Scholar 

  8. 8.

    Baron-Cohen, S., Wheelwright, S., Hill, J., Raste, Y. & Plumb, I. The “Reading the Mind in the Eyes” Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. The Journal of Child Psychology and Psychiatry and Allied Disciplines 42, 241–251 (2001).

    CAS  Article  Google Scholar 

  9. 9.

    Yu, R.-L. & Wu, R.-M. Social brain dysfunctions in patients with Parkinson’s disease: a review of theory of mind studies. Translational neurodegeneration 2, 7 (2013).

    Article  Google Scholar 

  10. 10.

    Shamay-Tsoory, S. G., Tomer, R., Berger, B. D., Goldsher, D. & Aharon-Peretz, J. Impaired “affective theory of mind” is associated with right ventromedial prefrontal damage. Cognitive and Behavioral Neurology 18, 55–67 (2005).

    CAS  Article  Google Scholar 

  11. 11.

    Hynes, C. A., Baird, A. A. & Grafton, S. T. Differential role of the orbital frontal lobe in emotional versus cognitive perspective-taking. Neuropsychologia 44, 374–383 (2006).

    Article  Google Scholar 

  12. 12.

    Alexander, G. E., DeLong, M. R. & Strick, P. L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9, 357–381, https://doi.org/10.1146/annurev.ne.09.030186.002041 (1986).

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Peron, J. et al. Are dopaminergic pathways involved in theory of mind? A study in Parkinson’s disease. Neuropsychologia 47, 406–414, https://doi.org/10.1016/j.neuropsychologia.2008.09.008 (2009).

    Article  PubMed  Google Scholar 

  14. 14.

    Enrici, I. et al. Emotion processing in Parkinson’s disease: a three-level study on recognition, representation, and regulation. PLoS One 10, e0131470, https://doi.org/10.1371/journal.pone.0131470 (2015).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Mehanna, R., Moore, S., Hou, J. G., Sarwar, A. I. & Lai, E. C. Comparing clinical features of young onset, middle onset and late onset Parkinson’s disease. Parkinsonism & related disorders 20, 530–534, https://doi.org/10.1016/j.parkreldis.2014.02.013 (2014).

    Article  Google Scholar 

  16. 16.

    Yoshimura, N., Yokochi, M., Kan, Y., Koyama, S. & Kawamura, M. Relatively spared mesocorticolimbic dopaminergic system in juvenile parkinsonism. Parkinsonism & related disorders 13, 483–488 (2007).

    Article  Google Scholar 

  17. 17.

    Gray, H. M. & Tickle-Degnen, L. A meta-analysis of performance on emotion recognition tasks in Parkinson’s disease. Neuropsychology 24, 176 (2010).

    Article  Google Scholar 

  18. 18.

    Clark, U. S., Neargarder, S. & Cronin-Golomb, A. Specific impairments in the recognition of emotional facial expressions in Parkinson’s disease. Neuropsychologia 46, 2300–2309 (2008).

    Article  Google Scholar 

  19. 19.

    Heller, J. et al. Impact of gender and genetics on emotion processing in Parkinson’s disease-A multimodal study. NeuroImage: Clinical 18, 305–314 (2018).

    Article  Google Scholar 

  20. 20.

    Guariglia, P. et al. The eyes test is influenced more by artistic inclination and less by sex. Frontiers in human neuroscience 9, 292 (2015).

    Article  Google Scholar 

  21. 21.

    Roca, M. et al. Impairments in social cognition in early medicated and unmedicated Parkinson disease. Cogn Behav Neurol 23, 152–158, https://doi.org/10.1097/WNN.0b013e3181e078de (2010).

    Article  PubMed  Google Scholar 

  22. 22.

    Roca, M. et al. The relationship between executive functions and fluid intelligence in Parkinson’s disease. Psychol Med 42, 2445–2452, https://doi.org/10.1017/S0033291712000451 (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Tsuruya, N., Kobayakawa, M. & Kawamura, M. Is “reading mind in the eyes” impaired in Parkinson’s disease? Parkinsonism Relat Disord 17, 246–248, https://doi.org/10.1016/j.parkreldis.2010.09.001 (2011).

    Article  PubMed  Google Scholar 

  24. 24.

    Rosen, J. B., Brand, M., Polzer, C., Ebersbach, G. & Kalbe, E. Moral decision-making and theory of mind in patients with idiopathic Parkinson’s disease. Neuropsychology 27, 562–572, https://doi.org/10.1037/a0033595 (2013).

    Article  PubMed  Google Scholar 

  25. 25.

    Bodden, M. E. et al. Affective and cognitive Theory of Mind in patients with parkinson’s disease. Parkinsonism Relat Disord 16, 466–470, https://doi.org/10.1016/j.parkreldis.2010.04.014 (2010).

    Article  PubMed  Google Scholar 

  26. 26.

    Euteneuer, F. et al. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson’s disease: a neuropsychological and psychophysiological study. Neuropsychologia 47, 2882–2890, https://doi.org/10.1016/j.neuropsychologia.2009.06.014 (2009).

    Article  PubMed  Google Scholar 

  27. 27.

    Poletti, M., Vergallo, A., Ulivi, M., Sonnoli, A. & Bonuccelli, U. Affective theory of mind in patients with Parkinson’s disease. Psychiatry Clin Neurosci 67, 273–276, https://doi.org/10.1111/pcn.12045 (2013).

    Article  PubMed  Google Scholar 

  28. 28.

    Rosen, J. B., Rott, E., Ebersbach, G. & Kalbe, E. Altered moral decision-making in patients with idiopathic Parkinson’s disease. Parkinsonism Relat Disord 21, 1191–1199, https://doi.org/10.1016/j.parkreldis.2015.08.016 (2015).

    Article  PubMed  Google Scholar 

  29. 29.

    Raffo De Ferrari, A. et al. Freezing of gait and affective theory of mind in Parkinson disease. Parkinsonism Relat Disord 21, 509–513, https://doi.org/10.1016/j.parkreldis.2015.02.023 (2015).

    Article  PubMed  Google Scholar 

  30. 30.

    McKinlay, A., Albicini, M. & Kavanagh, P. S. The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson’s disease. Neuropsychiatr Dis Treat 9, 1071–1076, https://doi.org/10.2147/NDT.S49104 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Harkness, K., Sabbagh, M., Jacobson, J., Chowdrey, N. & Chen, T. Enhanced accuracy of mental state decoding in dysphoric college students. Cognition & Emotion 19, 999–1025 (2005).

    Article  Google Scholar 

  32. 32.

    Assogna, F., Pontieri, F. E., Caltagirone, C. & Spalletta, G. The recognition of facial emotion expressions in Parkinson’s disease. Eur Neuropsychopharmacol 18, 835–848, https://doi.org/10.1016/j.euroneuro.2008.07.004 (2008).

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Adolphs, R. Neural systems for recognizing emotion. Current opinion in neurobiology 12, 169–177 (2002).

    CAS  Article  Google Scholar 

  34. 34.

    Phillips, M. L. et al. Neural responses to facial and vocal expressions of fear and disgust. Proceedings of the Royal Society of London B: Biological Sciences 265, 1809–1817 (1998).

    CAS  Article  Google Scholar 

  35. 35.

    Kirkland, R. A., Peterson, E., Baker, C. A., Miller, S. & Pulos, S. Meta-analysis Reveals Adult Female Superiority in” Reading the Mind in the Eyes Test”. North American Journal of Psychology 15 (2013).

  36. 36.

    Hoffmann, H., Kessler, H., Eppel, T., Rukavina, S. & Traue, H. C. Expression intensity, gender and facial emotion recognition: Women recognize only subtle facial emotions better than men. Acta psychologica 135, 278–283 (2010).

    Article  Google Scholar 

  37. 37.

    Nobis, L. et al. Theory of mind performance in Parkinson’s disease is associated with motor and cognitive functions, but not with symptom lateralization. Journal of Neural Transmission 124, 1067–1072 (2017).

    Article  Google Scholar 

  38. 38.

    Rosell-Clari, V. & González, B. V. Theory of Mind (ToM) and language: stimulating metalinguistic skills in people with dementia. CoDAS, https://doi.org/10.1590/2317-1782/20162015295 (2016).

    Article  Google Scholar 

  39. 39.

    Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry 55, 181–184 (1992).

    CAS  Article  Google Scholar 

  40. 40.

    Folstein, M. F., Folstein, S. E. & McHugh, P. R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189–198 (1975).

    CAS  Article  Google Scholar 

  41. 41.

    Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25, 2649–2653, https://doi.org/10.1002/mds.23429 (2010).

    Article  PubMed  Google Scholar 

  42. 42.

    Yu, R. L. et al. Cross‐Cultural Differences of the Non‐Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson’s Disease Rating Scale. Movement disorders clinical practice 4, 68–77 (2017).

    Article  Google Scholar 

Download references


The authors are grateful to the participants involved in this study and for the grants from the Ministry of Science and Technology (MOST), Taipei, Taiwan (MOST 106-2410-H-006-039-MY2, 105-2410-H-006-021, 104-2633-H-006-001, 103-2410-H-006-120-MY2, and 106-2314-B-037-097-MY2) and Kaohsiung Medical University (KMUH105-5M37 and KMUH106-6R66).

Author information




All authors fulfilled the criteria of authorship, and no one who fulfilled the criteria was excluded. R.L. Yu. and C.H. Tan carried out conceptualization and design of the study and contributed to the execution, critique, and revision of the data analysis and manuscript. R.L. Yu. executed data acquisition and wrote and edited the manuscript. C.H. Tan, P.S. Chen, W.C. Tsao, and S.C. Tu contributed to the sample collection and the critique of the manuscript. R.L. Yu. and C.H. Tan performed literature searches and data analysis and take responsibility for the interpretation of the results. All authors critically reviewed drafts and gave approval for the final version of this article. C.H. Tan accepts full responsibility for the work and controlled the decision to publish.

Corresponding author

Correspondence to Chun-Hsiang Tan.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yu, RL., Chen, P., Tu, SC. et al. Emotion-Specific Affective Theory of Mind Impairment in Parkinson’s Disease. Sci Rep 8, 16043 (2018). https://doi.org/10.1038/s41598-018-33988-6

Download citation


  • Affect Theory
  • Young-onset Parkinson’s Disease (YOPD)
  • Specific Motor Symptoms
  • Neutral Valence
  • Medical Care Program

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing